How fast can you get into the Emergency Room? Thanks to a new mobile app developed by UC San Diego data science undergraduate pair, there's a way to get care more effectively. Their TimER won the annual UC Health Hack, with a mobile application that works even without a smartphone
Biologists at UC San Diego have discovered a new way of re-sensitizing drug-resistant human tumor cells to the potency of DNA-damaging agents, the most widely used group of cancer drugs. In a new study, they describe how a human gene known as Schlafen 11 controls the sensitivity of tumor cells to DDAs. Their research may pave the way to new strategies to overcome chemotherapeutic drug resistance.
UC San Diego and the Foundation for Biomedical Research and Innovation at Kobe have entered into a five-year memo of understanding to promote joint research in the field of biomedicine.
Researchers have trained a machine learning algorithm to identify and predict which genes make infectious bacteria resistant to antibiotics. The approach was tested on strains of Mycobacterium tuberculosis—the bacteria that cause tuberculosis (TB) in humans. It identified 33 known and 24 new antibiotic resistance genes in these bacteria. The approach could be used to predict resistance in other infection-causing pathogens.
The mechanism leading to development of type 1 diabetes remains a mystery, hampering the ability to find new ways to prevent, treat or even cure this condition. With a new $3.3 million grant, University of California School of Medicine researchers hope to create a high resolution reference map of pancreatic cells that will identify molecular changes that arise during type 1 diabetes.
Invention Science Fund, the incubator arm of Intellectual Ventures, and San Diego’s Legler Benbough Foundation will contribute $1 million in combined sponsorship funds to the Institute for the Global Entrepreneur at the University of California San Diego to help accelerate new startup companies.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
